| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 54.83B | 54.83B | 51.90B | 49.00B | 36.65B | 32.93B |
| Gross Profit | 14.69B | 14.67B | 13.46B | 11.52B | 9.55B | 8.21B |
| EBITDA | 5.92B | 8.13B | 8.43B | 6.33B | 5.09B | 3.85B |
| Net Income | 4.35B | 4.81B | 5.10B | 3.75B | 2.75B | 1.94B |
Balance Sheet | ||||||
| Total Assets | 64.06B | 64.46B | 56.59B | 53.48B | 46.06B | 43.38B |
| Cash, Cash Equivalents and Short-Term Investments | 18.52B | 19.25B | 11.65B | 12.84B | 10.94B | 11.38B |
| Total Debt | 7.77B | 7.96B | 1.31B | 1.29B | 116.70M | 1.10B |
| Total Liabilities | 22.69B | 23.42B | 19.02B | 19.29B | 14.75B | 13.42B |
| Stockholders Equity | 41.20B | 40.87B | 37.41B | 34.04B | 31.16B | 29.83B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.06B | 1.78B | 1.76B | 1.15B | 2.11B |
| Operating Cash Flow | 0.00 | 3.91B | 3.97B | 2.87B | 2.28B | 4.10B |
| Investing Cash Flow | 0.00 | -1.08B | -2.76B | -867.94M | -615.90M | -2.02B |
| Financing Cash Flow | 0.00 | 4.37B | -2.49B | -158.97M | -2.22B | -1.73B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
84 Outperform | ¥56.79B | 6.96 | ― | 3.18% | 2.98% | 10.15% | |
78 Outperform | ¥69.04B | 9.50 | ― | 2.63% | -6.00% | -13.74% | |
76 Outperform | ¥57.26B | 10.64 | ― | 2.79% | 2.85% | 3.17% | |
75 Outperform | ¥64.47B | 13.24 | ― | 3.95% | -1.67% | -4.39% | |
74 Outperform | ¥57.34B | 24.26 | ― | 2.54% | 2.00% | 39.80% | |
70 Outperform | ¥87.94B | 4.09 | ― | 3.09% | 6.35% | -34.20% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |